Gene · 2886
GRB7: growth factor receptor bound protein 7
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GRB7: growth factor receptor bound protein 7. Genes, record 2886. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2886
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q14451 | Growth factor receptor-bound protein 7 | 532 | 14 | Ensembl, GeneID, HGNC |
Source UniProt
Patents44
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 48337 | Q14451 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 48340 | Q14451 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 48341 | Q14451 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 29277 | Q14451 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 29279 | Q14451 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 29281 | Q14451 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 29277 | Q14451 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 29279 | Q14451 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 29281 | Q14451 | Espacenet |
| US 12024722 B2 | 2024-07-02 | 51 | Q14451 | Espacenet |
1 to 10 of 44
See all 44 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants924
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GRB7 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 11 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 10 | 2025 |
| U54CA132383 | 1/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch | 9 | 2025 |
| P30ES017885 | Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD) | 5 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 5 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 4 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 4 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 4 | 2025 |
| P30CA072720 | Cancer Center Support Grant | 4 | 2025 |
| U54CA132381 | 2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch | 4 | 2025 |
1 to 10 of 924Source NIH's project files
See all 924 nih grantsPapers1,318
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Ancestry Genome-wide Association Analyses Identify Shared and Specific Genetic Architecture in Mild and Moderate-to-Severe Asthma. | medRxiv | 2026 | 42818167 | PubTator, text mining | PubMed |
| Integrated Analysis of HER2 Expression and ERBB2 Alterations in Bladder Cancer. | Cancer Sci | 2026 | 42732768 | PubTator, text mining | PubMed |
| A TMED3-governed disulfidptosis-related diagnostic signature reveals tumor microenvironment remodeling in intrahepatic cholangiocarcinoma. | Front Immunol | 2026 | 42591673 | PubTator, text mining | PubMed |
| Association of Increased MIEN1 Copy Number With Worse Outcomes in Lung Adenocarcinoma and Cervical Cancer. | Cureus | 2026 | 42540337 | PubTator, text mining | PubMed |
| miR-770-5p regulates KDM5B and links its nuclear localization to HER2 signaling in trastuzumab-resistant breast cancer. | Mol Cell Biochem | 2026 | 42474975 | PubTator, text mining | PubMed |
| Recurrence Score gene group components and outcomes in the RxPONDER trial (SWOG S1007). | J Natl Cancer Inst | 2026 | 42458791 | PubTator, text mining | PubMed |
| Single-cell analysis reveals that NRG1/3-ERBB4 signaling affects metabolic reprogramming and immune escape in Wilms tumor. | Biol Direct | 2026 | 42163376 | PubTator, text mining | PubMed |
| KCTD10 as a selective cancer dependency from transcription-replication conflicts (TRCs). | Ageing Cancer Res Treat | 2026 | 42037670 | PubTator, text mining | PubMed |
| Circular RNAs in cancer: Its biogenesis, functions, relationships with cancer progression, applications in immunotherapy and biomarker potentials. | Cancer Immunol Immunother | 2026 | 41915211 | PubTator, text mining | PubMed |
| A metrological foundation for absolute transcriptomics using International System of Units-anchored calibrators. | Nat Commun | 2026 | 41888124 | PubTator, text mining | PubMed |
1 to 10 of 1,318
See all 1,318 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2886
GET https://conductscience.org/api/genes/v1/2886/patents?page=2